← Back to homepage
AstraZeneca investors raise concerns over mega-merger talks
Sources
1
Coverage
Limited spectrum
Sentiment
0.00
◀ Left 0%Centre 100%Right 0% ▶
How we rate bias →This story is currently only covered by one source from a single part of the political spectrum. NewsDeck will update this page automatically if other outlets pick up the story.
NewsDeck Poll
Do you think this story is being covered fairly across the political spectrum?
Loading…
Left
(0)
No coverage from this perspective yet
Centre
(1)
FT UK
AstraZeneca investors raise concerns over mega-merger talks
Shareholders question looming patent cliff and antitrust risks in potential $400bn tie-up with Bristol Myers Squibb
3 Aug, 16:24
Right
(0)
No coverage from this perspective yet